. MK886 ameliorates Alzheimer's disease by activating the PRKCI/AKT signaling pathway. Eur J Pharmacol. 2025 Apr 15;993:177359. Epub 2025 Feb 7 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.